Concepedia

Sanda Jelisavac-Čosić

SJ

Statistics

Publications

3

Citations

54

H-Index

3

Active since

2009

Affiliations

University Hospital Centre Zagreb(Current)

Sanda Jelisavac-Čosić is an author at University Hospital Centre Zagreb specializing in pathology, medicine, and tumor biology.

Top concepts

Publications per year

2009–2012

3

Publications

3

Anti-p53 antibodies in serum: relationship to tumor biology and prognosis of breast cancer patients

Ana Kulić, Maja Sirotković-Skerlev, Sanda Jelisavac-Čosić et al. · Medical Oncology · 2009 · 25 citations

, , +11

Prognostic significance of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor (PAI-1) in patients with primary invasive ductal breast carcinoma - a 7.5-year follow-up study.

Sanda Jelisavac-Čosić, Maja Sirotković-Skerlev, Jasminka Jakić‐Razumović et al. · PubMed · 2012 · 16 citations

Prognostic significance of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor (PAI-1) in patients with primary invasive ductal breast carcinoma – a 7.5-year follow-up study

Sanda Jelisavac-Čosić, Maja Sirotković-Skerlev, Ana Kulić et al. · Tumori Journal · 2011 · 13 citations

1–3 of 3